We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Organovo Holdings Inc
13 own
15 watching
Current Price
$1.74
$0.05
(3.26%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
15.16M
52-Week High
4.67
52-Week Low
1.37
Average Volume
0.07M
Dividend Yield
--
P/E Ratio
35.1196
Market Capitalization15.16M52-Week High4.6752-Week Low1.37Average Volume0.07MDividend Yield--P/E Ratio35.1196What does the Organovo Holdings Inc do?
Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. It is developing a suite of standardized and three-dimensional human tissues for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology or disease for use in drug discovery and development; and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair, and functional tissue patches for the repair or replacement of damaged tissues and organs. The company has collaboration agreements with L'Oreal USA and Merck & Co. Organovo Holdings, Inc. was founded in 2007 and is headquartered in San Diego, California.
Read More
How much money does Organovo Holdings Inc make?
News & Events about Organovo Holdings Inc.
Globe Newswire
2 months ago
SAN DIEGO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology (3D biology) company focused on delivering scientific and medical breakthroughs using novel technologies including 3D bioprinting, today announced that it has successfully advanced the ...
Zolmax
11 months ago
Renaissance Technologies LLC trimmed its position in shares of Organovo Holdings, Inc. (NASDAQ:ONVO Get Rating) by 21.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,887 shares of the ...
Frequently Asked Questions
Frequently Asked Questions
What is Organovo Holdings Inc share price today?
Can Indians buy Organovo Holdings Inc shares?
How can I buy Organovo Holdings Inc shares from India?
Can Fractional shares of Organovo Holdings Inc be purchased?
What are the documents required to start investing in Organovo Holdings Inc stocks?
What is today’s traded volume of Organovo Holdings Inc?
What is today’s market capitalisation of Organovo Holdings Inc?
What is the 52-Week High and Low Range of Organovo Holdings Inc?
What percentage is Organovo Holdings Inc down from its 52-Week High?
What percentage is Organovo Holdings Inc up from its 52-Week Low?
Current Price
$1.74
$0.05
(3.26%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.